GH Research (GHRS) Current Assets (2021 - 2025)
GH Research (GHRS) recorded quarterly Current Assets of $286.0 million in Q4 2025, down 2.99% quarter-over-quarter from $294.8 million in Q3 2025, and up 85.43% on a YoY basis from $154.2 million in Q4 2024.
GH Research (GHRS) Current Assets (2021 - 2025) Analysis & Trends
GH Research's Current Assets history runs 5 years deep, the most recent figure standing at $286.0 million for Q4 2025.
- In Q4 2025, Current Assets rose 85.43% year-over-year to $286.0 million; the TTM figure through Dec 2025 stood at $286.0 million (up 85.43% YoY), while the FY2025 annual figure was $286.0 million, up 85.43% from the prior year.
- Current Assets was $286.0 million for Q4 2025 at GH Research, down from $294.8 million in the prior quarter.
- In the past five years, Current Assets ranged from a high of $294.8 million in Q3 2025 to a low of $152.9 million in Q2 2024.
- Historically, Current Assets has averaged $215.1 million across 5 years, with a median of $167.5 million in 2022.
- The sharpest annual moves came in 2023 and 2025: Current Assets slumped 39.77% in 2023, then soared 92.19% in 2025.
- A 5-year view of Current Assets shows it stood at $166.0 million in 2021, then increased by 1.51% to $168.5 million in 2022, then declined by 2.64% to $164.1 million in 2023, then fell by 6.01% to $154.2 million in 2024, then surged by 85.43% to $286.0 million in 2025.
- The last three Current Assets figures came in at $286.0 million (Q4 2025), $294.8 million (Q3 2025), and $293.9 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | 37.31 Mn |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | 521.86 Mn |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | 10.37 Mn |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 1.25 Bn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | 3.59 Mn |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | 7.63 Mn |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 11.73 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | 600.85 Mn |
| 10 | GH Research | 9.73 Bn | 9.63 Bn | - | 285.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 285.98 Mn |
| Sep 30, 2025 | 294.79 Mn |
| Jun 30, 2025 | 293.88 Mn |
| Mar 31, 2025 | 294.67 Mn |
| Dec 31, 2024 | 154.23 Mn |
| Sep 30, 2024 | 154.95 Mn |
| Jun 30, 2024 | 152.91 Mn |
| Mar 31, 2024 | 160.48 Mn |
| Dec 31, 2023 | 164.09 Mn |
| Sep 30, 2023 | 164.04 Mn |
| Jun 30, 2023 | 166.40 Mn |
| Mar 31, 2023 | 164.72 Mn |
| Dec 31, 2022 | 168.54 Mn |
| Sep 30, 2022 | 260.04 Mn |
| Jun 30, 2022 | 266.23 Mn |
| Mar 31, 2022 | 273.46 Mn |
| Dec 31, 2021 | 166.03 Mn |
| Sep 30, 2021 | 285.56 Mn |